Enlightening from optimizing post-authorization safety monitoring system of SARS-CoV-2 vaccines in major economies worldwide.
10.3760/cma.j.cn112150-20230116-00038
- Author:
Shen Yu WANG
1
;
Xue Jiao PAN
1
;
Xuan DENG
1
;
Jian FU
1
;
Hang Jie ZHANG
1
;
Lin Ling DING
1
;
Zhi Ping CHEN
2
Author Information
1. Department of Immunization Programme, Zhejiang Provincial Center for Diseases Control and Prevention, Hangzhou 310051, China.
2. Zhejiang Provincial Center for Diseases Control and Prevention, Hangzhou 310051, China.
- Publication Type:Journal Article
- MeSH:
Humans;
COVID-19/prevention & control*;
COVID-19 Vaccines;
Pandemics/prevention & control*;
SARS-CoV-2;
Viral Vaccines/adverse effects*
- From:
Chinese Journal of Preventive Medicine
2023;57(7):1096-1104
- CountryChina
- Language:Chinese
-
Abstract:
Ongoing global pandemic of Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has promoted the unprecedented rapid development and large-scale rolling out of different platform-based COVID-19 vaccines worldwide. How to effectively respond to the expected scale increasing adverse events after vaccination campaign of COVID-19 vaccines is a common problem faced by the world. A lot of countries and regions around the world have arranged in advance at different levels, optimizing the original vaccine safety monitoring system from the perspectives of strengthening the foundation and capabilities, promoting internal and external cooperation, upgrading methods, as well as improving transparency and public communication, which has ensured the good and efficient operation of the system and can provide reference for the construction of relevant fields in China.
